Schistosoma Haematobium Infections and Praziquantel (NCT01558336) | Clinical Trial Compass
CompletedPhase 3
Schistosoma Haematobium Infections and Praziquantel
Sudan520 participantsStarted 2008-08
Plain-language summary
The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.
Who can participate
Age range
6 Years – 15 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* School children
Exclusion Criteria:
* Taking praziquantel
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied praziquantel for schistosoma haematobium infections — is praziquantel already considered a standard treatment for this type of schistosomiasis, and how does what was learned in this Phase 3 trial compare to what's currently recommended for my situation?
2Since this trial was completed and measured cure rate as its main outcome, can you tell me what the actual cure rate results showed, and what that might mean for how likely praziquantel is to work for me?
3Because this was a Phase 3 trial, it was designed to confirm effectiveness in a larger group — does that mean there's now more established safety and dosing information about praziquantel that could apply to my care?
4Are there situations where praziquantel might not achieve a cure, and if that happened to me, what would the next treatment options look like?
5Given that this trial is now completed, is the data from it being used to guide treatment guidelines, and should I be asking about any follow-up studies or newer approaches that have come out since?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.